Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery | Last updated: August 20, 2026
What You Can Expect From Avéli
- Avéli is an FDA-cleared mechanical subcision device that cuts fibrous septae to soften cellulite dimples on the buttocks and thighs.
- The CONFFIRM pivotal trial showed sustained improvement and 93% patient satisfaction at 12 months after a single session.1
- Results are durable because released bands do not reattach, although new dimples can form in untreated areas or with weight changes.1
- Ideal candidates have discrete dimples, good skin elasticity, stable weight, and no prior liposuction in the treatment area.
- Schedule your cellulite assessment with Ellie at Mirror Plastic Surgery to see whether Avéli fits your cellulite pattern.
How Avéli Targets Cellulite Bands
Avéli received FDA 510(k) clearance K221336 on August 5, 2022, under product code OUP, the same classification established via De Novo DEN110004 for the original Cabochon System in 2013. The FDA confirmed that Avéli’s physical mechanism, mechanical cutting of fibrous septae in the subcutaneous tissue, is similar to the predicate Cellfina System, although Avéli uses a manual guided reciprocating mechanism rather than vacuum stabilization.
The procedural sequence follows a clear stepwise pattern. A probe with an integrated LED light tip is inserted for transillumination. The hook then captures individual fibrous septae, and visual and tactile feedback confirms capture when the dimple pulls downward. Once confirmed, a manual blade cuts the targeted band. This one-dimple-one-band approach matters because each visible dimple represents a distinct fibrous band that must be released separately. The procedure is performed under local anesthesia in-office and typically takes about an hour.
How Long Avéli Results Typically Last
The CONFFIRM study provides the main durability data for Avéli. Mean CSS improvement appeared at 3 months and remained stable at the 12‑month follow-up after a single treatment session.1 The near-identical scores at both time points show that results do not meaningfully decline during the first year. Patient satisfaction was high at 3 months and at 12 months1, and most patients showed improvement on the Global Aesthetic Improvement Scale (GAIS)1.
Beyond 12 months, the bands that are released do not reattach1. Researchers still do not know whether septa-targeting treatments can completely prevent cellulite recurrence, and longer-term data on cellulite biology will clarify this over time.
Cellulite Recurrence After Avéli
The released bands described earlier do not reattach, so treated dimples usually show lasting improvement. New dimples can still develop in untreated areas1, especially as body composition and skin quality change. Significant weight changes or natural aging over time may cause new dimples to appear.1
After significant weight loss, the septal network becomes elongated and weak, often requiring more complex procedures that address both septa and skin laxity. This structural change explains why weight stability is critical, because weight fluctuations can undermine previously treated areas by altering tissue architecture. The risk is particularly high in elderly females with high BMI, who face the greatest likelihood of developing or worsening cellulite due to age-related dermal atrophy combined with fat lobule hypertrophy. For these reasons, stable weight and consistent skin care are the most reliable factors for preserving Avéli outcomes.
Discuss your cellulite pattern with Ellie to review your anatomy and long-term risk factors for recurrence.
How Well Avéli Works on Legs
Avéli is indicated for adult women with cellulite on the buttocks and/or thighs. The light-guided probe suits thigh anatomy because its illuminated tip navigates curved surfaces without suction chambers, which gives it a technical advantage over vacuum-based predecessors on the contoured thigh surface.
Avéli works best for discrete, clearly identifiable dimples on the thighs. Patients whose cellulite blankets an entire area usually benefit less because the fibrous bands are too small and numerous to release individually. Diffuse rippling or wavy texture on the legs reflects a different anatomical pattern and does not respond to subcision alone.
Comparing Avéli, Cellulaze, and Qwo
Avéli, Cellulaze, and Qwo use different mechanisms and suit different problems.
Avéli and Cellfina are both mechanical subcision devices cleared under FDA product code OUP. Cellfina was cleared in 2015, and studies reported patient satisfaction of 96% at 2 years with sustained benefit at 3 years.1 Avéli offers a more targeted approach with real-time release verification, and Cellfina typically allows return to daily routine within a few days, with bruising resolving by the third week.
Cellulaze is a laser-assisted treatment that combines subcision with laser energy to release bands, reduce fat bulging, and stimulate collagen. Cellulaze can be particularly effective for deeper dimpling and addresses multiple factors at once, but recovery involves bruising and swelling for one to two weeks, and results may not last as long as mechanical subcision.
Qwo (collagenase clostridium histolyticum) no longer plays a role in cellulite treatment. Qwo was removed from the market due to concerns about the extent and variability of bruising after treatment and the potential for prolonged skin discoloration.
A 2026 development expanded combination options. A prospective study in Aesthetic Surgery Journal Open Forum evaluated a single-session combination of Avéli followed by Renuvion helium plasma radiofrequency in 22 patients, and at 180 days up to 81.8% showed improvement in cellulite appearance, with histological analysis confirming increases in collagen and elastin.1 This combination treats both fibrous septae and overlying skin quality, which may help patients who present with dimpling plus mild laxity.
Who Typically Qualifies for Avéli
Candidacy for Avéli depends on a detailed anatomical exam. The decision-tree table below summarizes key factors based on clinical evidence and published candidacy criteria.
| Assessment Factor | Favorable for Avéli | Requires Alternative or Combination | Clinical Basis |
|---|---|---|---|
| Cellulite type | Discrete dimples visible when standing, which soften when lying down or when tissue is lifted | Diffuse rippling, wavy horizontal folds, or laxity-driven texture | Structural dimples from vertical septae, while laxity may worsen with subcision |
| Body weight and BMI | At or near ideal body weight with a stable weight history | Considerable excess weight or recent significant weight fluctuation | Ideal candidates are at or near ideal body weight with good skin elasticity |
| Skin elasticity | Good skin elasticity without significant laxity | Significant skin laxity or loose, draping skin | Minimal skin laxity and good elasticity define the ideal candidate |
| Surgical history in area | No prior body-contouring surgery in the target area | Prior liposuction or plastic surgery on thighs or buttocks | Prior liposuction alters tissue anatomy and is a contraindication |
| Smoking status | Non-smoker | Active smoker | Nicotine impairs healing and increases bleeding risk |
Request a candidacy evaluation with Ellie at Mirror Plastic Surgery for a thorough top-to-bottom anatomical assessment.
What Recovery After Avéli Looks Like
Most patients resume normal activities within 24 to 48 hours after Avéli, and bruising and tenderness typically resolve within 30 days.1 Mild discomfort and fluid leakage from insertion points are expected for 24–48 hours, with bruising and swelling largely resolving by 2 weeks and final results apparent at 1–3 months.1
A standard post-procedure checklist includes:
- Wear compression garments as directed for the first several days to manage swelling.
- Expect mild soreness and bruising at insertion points for up to 30 days.
- Resume light daily activities within 24–48 hours.
- Avoid strenuous exercise and high-impact activity for the first few weeks.
- Keep insertion sites clean and monitor for signs of infection.
- Attend all scheduled follow-up appointments to assess tissue healing.
When Avéli Is Not the Right Choice
Certain anatomical and medical factors make Avéli inappropriate. The table below summarizes absolute and relative contraindications drawn from clinical candidacy literature.
| Red Flag | Reason for Exclusion | Potential Alternative | Clinical Basis |
|---|---|---|---|
| Significant skin laxity | Subcision does not improve laxity and may worsen it | Energy-based tightening (radiofrequency, Renuvion), or surgical lifting | Laxity patients are poor subcision candidates |
| High BMI or significant excess weight | Fat lobule hypertrophy exacerbates dimpling beyond what septal release can address | Weight stabilization first, then reassess | High BMI is associated with the greatest cellulite severity |
| Prior liposuction in treatment area | Altered tissue anatomy affects device navigation and release accuracy | In-person evaluation required to determine options | Prior surgery may alter tissue anatomy affecting Avéli application |
| Active skin infection in treatment area | Insertion through infected tissue poses systemic infection risk | Treat infection first and defer procedure | Active skin infections are a contraindication |
| Pregnancy | Minimally invasive procedures under local anesthesia are contraindicated during pregnancy | Defer until postpartum and weight-stable | Pregnancy is a contraindication for Avéli |
Alternatives to Avéli for Cellulite
When Avéli is not the right fit, several evidence-supported alternatives can address cellulite or related concerns, depending on the main anatomical issue.
- Energy-based devices (radiofrequency, laser, ultrasound): Best suited for patients with mild-to-moderate laxity or diffuse texture irregularity rather than discrete dimples. These modalities offer moderate results and typically require multiple sessions with minimal recovery.
- Renuvion (helium plasma radiofrequency): Focuses on skin quality and laxity. When combined with Avéli in a 2026 study, histological analysis confirmed increases in collagen and elastin with improved dermal architecture. Renuvion may also work as a standalone option for laxity-predominant presentations.
- Biostimulatory injectables (e.g., Radiesse and alloClae): Improve skin quality and provide volumetric correction in areas such as the buttocks. Mirror Plastic Surgery’s non-surgical BBL approach uses biostimulatory fillers to smooth texture and address contour concerns in the gluteal region.
- Lifestyle and weight stabilization: Does not treat existing dimples but sets the foundation for durable outcomes from any cellulite intervention. Treatments targeting fibrous septa produce more significant and durable improvement than modalities addressing only microcirculation or inflammation, yet weight stability remains essential.
- Cellfina: A mechanical subcision alternative with 96% patient satisfaction at 2 years, suited for broad, discrete buttock dimples when longer-studied durability data is a priority.
Frequently Asked Questions
Is there any cellulite treatment that actually works?
Some cellulite treatments work well when matched to the correct anatomical cause. Cellulite driven by fibrous septae that pull the skin downward responds most durably to mechanical subcision devices like Avéli. Clinical data from the CONFFIRM trial shows 93% patient satisfaction at 12 months after a single Avéli session. Treatments that address only surface texture, circulation, or fat, such as creams, massage, or cryolipolysis, do not sever the structural bands responsible for dimpling and usually produce temporary or minimal results. An in-person anatomical assessment remains the only reliable way to determine which treatment category fits a specific patient’s presentation.
What is the best cellulite treatment in 2026?
No single treatment works best for every patient. For discrete dimples caused by fibrous septae on the buttocks and thighs, Avéli is currently the most precisely targeted FDA-cleared option, with real-time release verification and a 24–48 hour return-to-activity profile. For patients with both dimpling and skin laxity, a 2026 study in Aesthetic Surgery Journal Open Forum showed that combining Avéli with Renuvion helium plasma radiofrequency produced improvement in up to 81.8% of patients at 180 days, with histological evidence of collagen and elastin remodeling. For patients whose primary concern is laxity rather than dimpling, energy-based tightening devices are usually more appropriate. The best choice depends on a thorough anatomical assessment.
How long does it take for Avéli to work?
Improvement in dimple appearance often becomes visible once initial swelling subsides, typically within the first few days. Bruising and swelling largely resolve by 2 weeks. Final results usually appear at 1–3 months as tissues complete healing and remodeling. The CONFFIRM study reported that patient satisfaction increased from 80% at 3 months to 93% at 12 months, which suggests that outcomes continue to improve as tissue settles.1 Patients should avoid judging their final result during the acute recovery phase.
What do dermatologists recommend for cellulite on legs?
Clinical consensus favors treatments that address the structural cause of cellulite, the fibrous septae, over surface-level modalities. For discrete dimples on the thighs, FDA-cleared subcision devices such as Avéli rank among the most evidence-supported options, and the light-guided probe suits the curved anatomy of the thigh. For diffuse rippling or laxity on the legs, energy-based devices or combination approaches usually work better. Dermatologists and plastic surgeons consistently report that creams, rollers, and massage do not create durable structural change. An in-person evaluation that distinguishes dimple-type cellulite from laxity-driven texture is the standard first step before any treatment plan.
Conclusion and Next Steps
Avéli is a well-characterized, FDA-cleared subcision device with a defined mechanism, a 12‑month pivotal dataset, and a clear anatomical scope. The CONFFIRM study’s 1.48‑point CSS improvement and 93% satisfaction at one year represent some of the strongest durability evidence currently available for a single-session minimally invasive cellulite treatment. Those results depend on correct patient selection, particularly the identification of discrete fibrous-septae-driven dimples in patients with good skin elasticity, stable weight, and no prior liposuction in the treatment area.
At Mirror Plastic Surgery in St. Petersburg, Avéli is offered within a concierge framework that prioritizes safety first, function second, and aesthetics third. Consultations can extend up to an hour and include a top-to-bottom anatomical assessment to determine whether Avéli, a combination approach, or an alternative modality best serves each patient’s anatomy and long-term goals. This approach directly addresses a common failure point in cellulite treatment, which occurs when a structural intervention is applied to a non-structural problem.
Get your personalized cellulite treatment plan with Ellie at Mirror Plastic Surgery for a thorough, evidence-based assessment and an honest recommendation tailored to your anatomy.
Disclaimer: Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
